Back to Agenda
OS15 The Additional Pharmacovigilance Plan: Role in Japan
Session Chair(s)
Yumiko Suzuki, PHD
Senior Director, PMS Affairs, Pfizer R&D Japan, Japan
Speaker(s)
Tetsuya Kanayama
Head, CDD3 CDD & Re-examination Clinical Development & Analytics, Novartis Pharma K.K., Japan
Kanami Sugimoto
, Suzuken Co., Ltd., Japan
Ryo Nakajima, MS
Manager, Medical, AbbVie GK, Japan
Have an account?